KR20230058792A - An anti-drunkenness and hangover-alleviating composition and its preparation method - Google Patents

An anti-drunkenness and hangover-alleviating composition and its preparation method Download PDF

Info

Publication number
KR20230058792A
KR20230058792A KR1020210142434A KR20210142434A KR20230058792A KR 20230058792 A KR20230058792 A KR 20230058792A KR 1020210142434 A KR1020210142434 A KR 1020210142434A KR 20210142434 A KR20210142434 A KR 20210142434A KR 20230058792 A KR20230058792 A KR 20230058792A
Authority
KR
South Korea
Prior art keywords
extract
total flavanone
total
green tea
flavanone extract
Prior art date
Application number
KR1020210142434A
Other languages
Korean (ko)
Inventor
원 리우
Original Assignee
상하이 핀마이 인터 테크 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 상하이 핀마이 인터 테크 컴퍼니 리미티드 filed Critical 상하이 핀마이 인터 테크 컴퍼니 리미티드
Priority to KR1020210142434A priority Critical patent/KR20230058792A/en
Publication of KR20230058792A publication Critical patent/KR20230058792A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/10Drying, dehydrating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/26Homogenisation
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/31Mechanical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

According to the present invention, disclosed are an anti-intoxication and hangover-alleviating composition and a manufacturing method thereof. The main ingredient includes one or more selected from a bezoa total flavanone extract, a pseudoginseng total flavanone extract, and a green tea total flavanone extract. The anti-intoxication and hangover-alleviating composition improves an intoxication threshold and alleviates or reduces the symptoms of intoxication.

Description

항만취 및 숙취해소 조성물 및 그의 제조방법{An anti-drunkenness and hangover-alleviating composition and its preparation method}An anti-drunkenness and hangover-alleviating composition and its preparation method}

본 발명은 의약 분야, 특히 항만취 및 숙취해소 기능을 갖는 조성물 및 그의 제조 방법에 관한 것이다.The present invention relates to the field of medicine, particularly to a composition having anti-drunk and hangover-relieving functions and a method for preparing the same.

적당한 음주는 사람들의 신체 건강에 도움이 된다. 그러나 과도한 음주는 만취를 유발하고 현기증, 두통, 숙취, 음주 후 잘못된 행동 등을 유발하여 정상적인 업무 및 대인 커뮤니케이션에 지장을 줄 수 있다. 더 심각한 것은 과도한 음주가 신체 조직과 기관을 손상시킬 수 있다는 것이다. 예를 들어, 지속적인 과음은 간세포를 손상시키고 간의 정상적인 신진대사를 방해하여 알코올성 간염과 간경변증을 유발할 수 있다. 또한, 잦은 음주는 알코올 의존을 유발할 수 있다. 즉, 갑자기 금주하거나 음주량을 줄이게 되면 다양한 불쾌한 신체 증상이 나타나게 되는데, 이를 알코올 금단 증후군이라고도 한다.Moderate drinking is beneficial to people's physical health. However, excessive drinking causes drunkenness, dizziness, headache, hangover, and misbehavior after drinking, which can interfere with normal work and interpersonal communication. Even worse, excessive drinking can damage body tissues and organs. For example, continuous heavy drinking can damage liver cells and disrupt normal metabolism in the liver, leading to alcoholic hepatitis and cirrhosis. Also, frequent drinking can lead to alcohol dependence. In other words, when you suddenly stop drinking or reduce the amount of drinking, various unpleasant physical symptoms appear, which is also called alcohol withdrawal syndrome.

따라서 사람들은 음주로 인한 불편함을 완화하기 위해 다양한 방법을 사용하며 시장에는 많은 해당 판매 제품이 있다. 그러나 대부분의 제품에는 부정확한 치료 효과가 있다.Therefore, people use various methods to alleviate the discomfort caused by drinking, and there are many corresponding products on the market. However, most products have imprecise therapeutic effects.

상기와 같은 문제점을 해결하기 위하여, 본 발명은 많은 실험을 통하여 새로운 항만취 및 숙취해소 조성물을 제안한다. 상기 조성물은 음주자의 만취 역치를 현저히 개선하고, 만취로 인한 현기증, 통제 불능 행동 등과 같은 만취 및 신체 불편함을 예방하고, 대상자의 알코올 금단 증후군을 완화시킬 수 있다. 또한, 상기 조성물은 알코올의 분해를 촉진하고 간세포에 대한 알코올의 손상을 완화시킬 수 있는 간 보호 성분을 포함하여 이상적인 항만취 및 숙취해소 제품이다.In order to solve the above problems, the present invention proposes a new anti-drunk and hangover-relieving composition through many experiments. The composition can significantly improve the intoxication threshold of a drinker, prevent intoxication and physical discomfort such as dizziness and uncontrollable behavior due to intoxication, and alleviate alcohol withdrawal syndrome in a subject. In addition, the composition is an ideal anti-drunk and anti-hangover product, including a liver-protecting component capable of accelerating the decomposition of alcohol and mitigating the damage of alcohol to hepatocytes.

상기 기술적 목적을 달성하기 위해, 본 발명은 다음과 같은 기술적 해결책을 채택한다:To achieve the above technical objectives, the present invention adopts the following technical solutions:

항만취 및 숙취해소용 조성물은 베조아 총 플라바논 추출물(Bezoar total flavanone extract), 유사 인삼 총 플라바논 추출물(Pseudo-ginseng total flavanone extract ) 및 녹차 총 플라바논 추출물(Green tea total flavanone extract)로부터 선택된 하나 이상을 주성분으로 포함하다.The composition for anti-drinking and relieving hangover is selected from Bezoar total flavanone extract, pseudo-ginseng total flavanone extract, and green tea total flavanone extract. contain one or more as main constituents.

바람직하게는, 주성분은 중량부(weight part)로 베조아 총 플라바논 추출물 0-40, 유사 인삼 총 플라바논 추출물 0-40 및 녹차 총 플라바논 추출물 20-100을 포함한다.Preferably, the main ingredients include bezoa total flavanone extract 0-40, ginseng total flavanone extract 0-40 and green tea total flavanone extract 20-100 by weight part.

바람직하게는, 베조아 총 플라바논 추출물의 총 플라바논 함량은 >50%이고, 유사 인삼 총 플라바논 추출물의 총 플라바논 함량은 >80%이고, 녹차 총 플라바논 추출물의 총 플라바논 함량은 >80%이다.Preferably, the total flavanone content of the bezoa total flavanone extract is >50%, the total flavanone content of the pseudoginseng total flavanone extract is >80%, and the total flavanone content of the green tea total flavanone extract is > It is 80%.

베조아 총 플라바논 추출물, 유사 인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물은 다음과 같은 방법으로 제조된다:Bezoa total flavanone extract, pseudoginseng total flavanone extract and green tea total flavanone extract were prepared by the following methods:

베조아, 유사 인삼 및 녹차를 분쇄하는 단계; 상기 분쇄된 결과물을 각각 70% 미만 농도의 물 또는 에탄올로 추출하는 단계; 추출된 용액을 회수하는 단계; 원심분리 단계; 추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하는 단계; 40-50℃에서 진공 건조하는 단계; 및 각 추출물의 함량이 요구 사항을 충족하는지 확인하기 위해 검사하는 단계.Grinding bezoa, pseudo ginseng and green tea; Extracting the pulverized product with water or ethanol at a concentration of less than 70%, respectively; recovering the extracted solution; centrifugation step; performing extraction, macroporous resin column chromatography or recrystallization; vacuum drying at 40-50 ° C; and inspecting to ensure that the content of each extract meets the requirements.

본 발명의 항만취 및 숙취해소용 조성물은 β-시클로덱스트린, 말토덱스트린 및 스테비오사이드 중에서 선택된 1종 이상을 포함하는 보조성분을 더 포함한다.The anti-drunk and hangover-relieving composition of the present invention further includes an auxiliary component including at least one selected from β-cyclodextrin, maltodextrin, and stevioside.

바람직하게는 주성분과 보조성분의 중량비는 1:(0-3)이다.Preferably, the weight ratio of the main component to the auxiliary component is 1:(0-3).

본 발명은 또한 하기 단계를 포함하는 항만취 및 숙취해소 조성물의 제조방법을 개시한다:The present invention also discloses a method for preparing an anti-drunk and hangover-relieving composition comprising the following steps:

(1) 베조아, 유사 인삼 및 녹차를 분쇄하고; 상기 분쇄된 결과물을 각각 70% 미만 농도의 물 또는 에탄올로 추출하고; 추출된 용액을 회수하는 단계; 원심분리하고; 추출, 침강, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조하는 단계; 각 추출물의 함량이 요구 사항을 충족하는지 확인하여 베조아 총 플라바논 추출물, 유사 인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물을 얻고; 및 각각의 추출물을 분쇄하고 60메시체로 체과하는 단계;(1) crushing bezoa, ginseng pseudoginseng and green tea; Extracting the pulverized product with water or ethanol at a concentration of less than 70%, respectively; recovering the extracted solution; centrifuged; performing extraction, sedimentation, macroporous resin column chromatography or recrystallization; vacuum drying at 40-50 ° C; verifying whether the content of each extract meets the requirements to obtain bezoa total flavanone extract, pseudoginseng total flavanone extract and green tea total flavanone extract; And crushing each extract and sieving through a 60 mesh sieve;

(2) 베조아 총 플라바논 추출물 0-40, 녹차 총 플라바논 추출물 0-40 및 녹차 총 플라바논 추출물 20-100을 중량부로 칭량하고, 이들을 균일하게 혼합하여 주성분을 얻는 단계;(2) weighing 0-40 parts of bezoa total flavanone extract, 0-40 green tea total flavanone extract and 20-100 green tea total flavanone extract by weight, and mixing them uniformly to obtain a main component;

(3) β-시클로덱스트린 0-100 및 말토덱스트린 0-100을 중량부로 칭량하여 주성분과 균일하게 혼합하고, 전체 중량에 대하여 10-50%의 물을 첨가하고 갈기(grinding), 진공건조, 분쇄 및 60 메쉬 체로 체질을 단계; 그리고(3) Weigh 0-100 β-cyclodextrin and 0-100 maltodextrin by weight, mix them uniformly with the main component, add 10-50% of water based on the total weight, and grind, vacuum dry, and grind and sieving through a 60 mesh sieve; and

(4) 스테비오사이드 0~20중량부를 첨가하여 균일하게 혼합, 멸균, 펠렛화하여 캡슐제, 정제 또는 연약제로 제조하는 단계.(4) Adding 0 to 20 parts by weight of stevioside, mixing uniformly, sterilizing, and pelletizing to prepare capsules, tablets or soft medicines.

본 발명에 따른 항만취 및 숙취해소 조성물은 녹차를 주성분으로 하고, 상기 베조아 및 녹차를 보조성분으로 포함한다. 지원자에 대한 효과를 관찰한 결과, 항만취 및 숙취해소 조성물은 만취 역치 개선 및 만취 증상의 완화 또는 감소 효과가 있음이 입증되었다.The anti-drunk and hangover-relieving composition according to the present invention contains green tea as a main component and the bezoa and green tea as auxiliary components. As a result of observing the effect on volunteers, it was proved that the anti-drunk and hangover-relieving composition has an effect of improving the threshold of intoxication and alleviating or reducing symptoms of intoxication.

이하, 구체적인 실시예를 들어 본 발명을 더욱 설명하지만, 본 발명은 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be further described with reference to specific examples, but the present invention is not limited to these examples.

실시예 1Example 1

베조아 총 플라바논 추출물, 유사 인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물의 제조(The preparation of Bezoar total flavanone extract, Pseudo-ginseng total flavanone extract and Green tea total flavanone extract)The preparation of Bezoar total flavanone extract, Pseudo-ginseng total flavanone extract and Green tea total flavanone extract

목적하는 베조아 총 플라바논 추출물은:The desired bezoa total flavanone extract is:

베조아를 분쇄하고; 분쇄된 베조아를 60% 에탄올로 가열 환류하여 추출하고; 추출된 용액을 회수하고; 원심분리하고; 상층액을 수집하고; 거대다공성 수지 컬럼 크로마토그래피를 수행하여 총 플라본 풍부 분량을 얻고; 용매를 회수하고; 농축하고; 40-50℃에서 진공 건조하고; 총 플라본 함량이 >50%임을 확인하기 위해 검사하는 단계에 의해 제조된다.crushing bezoa; The pulverized bezoa was extracted by heating under reflux with 60% ethanol; recovering the extracted solution; centrifuged; Collect the supernatant; Macroporous resin column chromatography was performed to obtain total flavone enrichment fractions; recover the solvent; concentrate; vacuum dried at 40-50° C.; It is prepared by a step of testing to ensure that the total flavone content is >50%.

목적하는 유사 인삼 총 플라바논 추출물은:The target ginseng-like total flavanone extract is:

유사 인삼을 분쇄하고; 분쇄된 유사 인삼을 40% 에탄올로 초음파 추출하고;; 추출된 용액을 회수하고; 원심분리하고; 상층액을 수집하고; 에틸 아세테이트로 추출하여 총 플라본 풍부 분량을 얻고; 용매를 회수하고; 농축하고; 40-50℃에서 진공 건조하고; 및 총 플라본 함량이 >80%임을 확인하기 위해 검사하는 단계에 의해 제조된다.Grinding pseudo ginseng; Ultrasonic extraction of pulverized pseudo ginseng with 40% ethanol; recovering the extracted solution; centrifuged; Collect the supernatant; Extraction with ethyl acetate to obtain total flavone enrichment; recover the solvent; concentrate; vacuum dried at 40-50° C.; and testing to ensure that the total flavone content is >80%.

목적하는 녹차 총 플라바논 추출물은:The desired green tea total flavanone extract is:

녹차를 분쇄하고; 분쇄된 녹차를 60% 에탄올로 가열 환류하여 추출하고; 추출된 용액을 회수하고; 원심분리하고; 상층액을 수집하고; 재결정화를 수행하여 총 플라본 풍부 분량을 얻고; 40-50℃에서 진공 건조하고; 및 총 플라본 함량이 >80%임을 확인하기 위해 검사하는 단계에 의해 제조된다.grinding green tea; The ground green tea was extracted by heating under reflux with 60% ethanol; recovering the extracted solution; centrifuged; Collect the supernatant; Recrystallization is performed to obtain the total flavone enrichment fraction; vacuum dried at 40-50°C; and testing to ensure that the total flavone content is >80%.

실시예 2Example 2

베조아 총 플라바논 추출물, 유사 인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물을 주성분으로 하고, 베타-시클로덱스트린을 보조 성분으로 함유하는 항만취 및 숙취해소 캡슐은 다음 단계를 통해 제조된다:Anti-drunk and hangover-relieving capsules containing bezoa total flavanone extract, pseudoginseng total flavanone extract and green tea total flavanone extract as main components and beta-cyclodextrin as auxiliary ingredient are prepared through the following steps:

(1) 상기 실시예 1에서 제조된 베조아 총 플라바논 추출물 500g, 유사 인삼총 플라바논 추출물 500g 및 녹차 총 플라바논 추출물 5000g을 칭량하여 분쇄하고 60메쉬로 체과하고; β-시클로덱스트린 4000g을 칭량하여 상기 재료들을 균일하게 혼합하는 단계;(1) 500 g of the total flavanone extract of Bezoa, 500 g of the total flavanone extract of Panax ginseng, and 5000 g of total flavanone extract of green tea prepared in Example 1 were weighed and ground, and sieved through a 60 mesh; Weighing 4000 g of β-cyclodextrin and uniformly mixing the above materials;

(2) 물 3000ml를 가하고, 갈기를 반복하고, 수분 함량이 <5%가 될 때까지 40-50℃에서 진공 건조하고, 분쇄하고, 60망체로 체과(sieve)하는 단계;(2) adding 3000 ml of water, repeating grinding, vacuum drying at 40-50° C. until the moisture content is <5%, crushing, and sieving through a 60 mesh sieve;

(3) 살균을 수행한 후 20-40% 습도 환경에서 펠렛화하여 20-40 메쉬의 입자를 얻는 단계; 그리고(3) sterilization and then pelletizing in a 20-40% humidity environment to obtain particles of 20-40 mesh; and

(4) 습도 50% 이하의 환경에서 입자를 캡슐에 충전하여 각각의 중량이 0.5g인 캡슐들을 얻는 단계(4) obtaining capsules each weighing 0.5 g by filling the particles into capsules in an environment of 50% or less humidity.

투여방법 및 용법: 경구투여, 1회 2캡슐, 음주(drinking) 30분 전에 따뜻한 물과 함께 투여.Administration method and usage: Oral administration, 2 capsules at a time, administration with warm water 30 minutes before drinking.

실시예 3Example 3

녹차 총 플라바논 추출물을 주성분으로 하고, β-시클로덱스트린, 말토덱스트린 및 스테비오사이드를 보조성분으로 함유하는 항만취 및 숙취해소 지약(electuary)은 다음의 단계를 통해 제조된다:An anti-drunk and anti-hangover electuary containing green tea total flavanone extract as a main component and β-cyclodextrin, maltodextrin and stevioside as auxiliary components is prepared through the following steps:

(1) 상기 실시예 1에서 제조된 녹차 총 플라바논 추출물 5000g을 칭량하고, β-시클로덱스트린 5000g과 말토덱스트린 5000g을 칭량하여 이들을 균일하게 혼합하는 단계;(1) weighing 5000 g of the total flavanone extract of green tea prepared in Example 1, weighing 5000 g of β-cyclodextrin and 5000 g of maltodextrin, and mixing them uniformly;

(2) 물 5000ml를 가하고, 분쇄를 반복하고, 수분 함량이 <5%가 될 때까지 40-50℃에서 진공 건조하고, 분쇄하고, 60-메취 체로 체과하는 단계;(2) adding 5000 ml of water, repeating milling, vacuum drying at 40-50° C. until the moisture content is <5%, milling, and sieving through a 60-metre sieve;

(3) 스테비오사이드 1000g을 첨가하여 균일하게 혼합한 후, 살균 후 20-40% 습도 환경에서 펠렛화하여 20-40 mesh의 입자를 얻는 단계; 그리고(3) adding 1000 g of stevioside, mixing uniformly, and then pelletizing in a 20-40% humidity environment after sterilization to obtain particles of 20-40 mesh; and

(4) 습도 50% 이하의 환경하에서 입자를 백(bag)에 채우고, 각각의 무게가 2g인 백에 담긴 지약들을 얻는 단계.(4) Filling the bag with particles under an environment of 50% or less humidity, and obtaining pills contained in the bag each weighing 2 g.

투여방법 및 용법 : 경구투여, 1회 2포씩, 음주 전 또는 후 30분에 투여(끓는 물에 지사가 녹은 후).Administration method and usage: Oral administration, 2 packets at a time, administered 30 minutes before or after drinking (after dissolving the branch in boiling water).

실시예 4Example 4

유사인삼 총 플라바논 추출물과 녹차 총 플라바논 추출물을 주성분으로 하고, β-시클로덱스트린과 말토덱스트린을 보조성분으로 함유하는 항만취 및 숙취해소 정제는 다음 단계를 통해 제조된다:The anti-drunk and hangover-relieving tablets containing pseudoginseng total flavanone extract and green tea total flavanone extract as main components and β-cyclodextrin and maltodextrin as auxiliary components are prepared through the following steps:

(1) 상기 실시예 1에서 제조된 유사인삼 총 플라바논 추출물 300g 및 녹차 총 플라바논 추출물 2500g을 칭량하고; β-시클로덱스트린 2500g과 말토덱스트린 2500g을 칭량하여 상기 재료들을 균일하게 혼합하는 단계;(1) 300 g of pseudoginseng total flavanone extract and 2500 g of green tea total flavanone extract prepared in Example 1 were weighed; Weighing 2500 g of β-cyclodextrin and 2500 g of maltodextrin and mixing the materials uniformly;

(2) 살균을 수행한 후 20-40% 습도 환경에서 펠렛화하여 20-40 메쉬의 입자를 얻고 이를 타정하여 각각의 중량이 0.3g인 정제를 얻는 단계.(2) After performing sterilization, pelletizing in a 20-40% humidity environment to obtain particles of 20-40 mesh and tableting them to obtain tablets each having a weight of 0.3 g.

투여방법 및 용법: 경구투여, 1회 2-3정, 음주 전 또는 후 30에 경구 투여.Administration method and usage: Oral administration, 2-3 tablets at a time, orally administered before or after drinking for 30 days.

실험예 1Experimental Example 1

실시예 2에서 제조한 항만취 숙취해소 캡슐의 효과 관찰Observation of the effect of anti-drunk hangover relief capsules prepared in Example 2

캡슐은 30명의 지원자에 의해 테스트되었다. 음주 30분 전에 2캡슐을 투여하였고, 음주 후 현기증 및 만취 증상을 관찰하였다. 30명의 지원자 전원은 캡슐이 효과적이고, 음주자의 만취를 유발하는 알코올의 양을 크게 증가시키고, 만취 및 현기증 및 제어 상실 행동과 같은 신체 불편을 예방할 수 있다는 피드백을 받았다. 음주로 인한. 대표적인 예는 다음과 같다:The capsule was tested by 30 volunteers. Two capsules were administered 30 minutes before drinking, and dizziness and intoxication symptoms were observed after drinking. All 30 volunteers received feedback that the capsules were effective, significantly increased the amount of alcohol that made drinkers intoxicated, and prevented drunkenness and physical discomforts such as dizziness and loss of control behavior. caused by drinking. Representative examples include:

평소에 아주 소량의 맥주를 마신 후 어지러움을 호소하던 40세 남성 지원자(성씨는 "Shen")에게 음주 30분 전에 2캡슐을 투여하였고, 52% 와인 100g을 마신 후에도 현기증을 느끼지 않았다. A 40-year-old male volunteer (surname "Shen") who usually complained of dizziness after drinking a very small amount of beer was administered 2 capsules 30 minutes before drinking, and did not feel dizzy even after drinking 100g of 52% wine.

평소 맥주 4병을 마신 후 어지러움을 호소하던 22세 남성 지원자(성씨는 "Fu")에게 음주 30분 전에 2캡슐을 투여하였으며, 맥주 7병을 마신 후에도 현기증을 느끼지 않았다.A 22-year-old male volunteer (surname "Fu") who complained of dizziness after drinking 4 bottles of beer was administered 2 capsules 30 minutes before drinking, and did not feel dizzy even after drinking 7 bottles of beer.

시험예 2Test Example 2

실시예 3에서 제조한 항만취 및 숙취해소 지약의 효과 관찰Observation of the effects of the anti-drunk and hangover pills prepared in Example 3

본 발명의 지약이 5명의 자원 봉사자에 의해 테스트되었다. 음주로 인한 어지러움을 느낀 후 지약 2포를 투여한 결과, 현기증 증상의 완화 효과가 관찰되었다. 5명의 자원 봉사자 모두는 다음과 같은 피드백을 제공했다:The drug of the present invention was tested by 5 volunteers. As a result of administering 2 packets of Earth Medicine after feeling dizzy due to drinking, the effect of alleviating the symptoms of dizziness was observed. All five volunteers provided the following feedback:

지약은 효과적이었고, 현기증 증상을 완화하고, 만취 시간을 단축할 수 있었다.The pill was effective, relieved symptoms of dizziness, and shortened the intoxication time.

시험예 3Test Example 3

실시예 4에서 제조한 항만취 숙취해소 정제의 효과 관찰Observation of the effect of anti-drunk hangover relief tablets prepared in Example 4

본 발명의 정제는 16명의 지원자에 의해 테스트되었다. 음주 30분 전에 2정을 투여하였고, 음주 후 현기증 및 만취 증상을 관찰하였다. 그 중 15명의 지원자는 정제가 효과적이고, 음주자의 만취를 유발하는 알코올의 양을 현저히 증가시킬 수 있고, 만취를 예방하고 음주로 인한 현기증 및 통제력 상실 행동과 같은 신체 불편함 등을 예방할 수 있다는 피드백을 주었다. 대표적인 예는 다음과 같다.The tablets of the present invention were tested by 16 volunteers. Two tablets were administered 30 minutes before drinking, and dizziness and intoxication symptoms were observed after drinking. Among them, 15 volunteers gave feedback that the tablets are effective, can significantly increase the amount of alcohol that causes drinkers to become intoxicated, prevent drunkenness and physical discomfort such as dizziness and loss of control behavior caused by drinking. gave Representative examples include:

평소 술을 많이 마시고 곧 현기증을 느끼는 31세 남성 지원자(성씨는 "Gao"))에게 음주 30분 전에 2정을 투여하였으며, 52% 화이트와인 100g을 마신 후에도 현기증을 느끼지 않았다. A 31-year-old male volunteer (surname "Gao") who drank a lot and felt dizzy soon took 2 tablets 30 minutes before drinking, and did not feel dizzy even after drinking 100g of 52% white wine.

화이트와인은 마시지 않고 맥주 한 병만 마신 후 평소에 어지럼증을 앓던 36세 남성 지원자(성씨는 "Zhang")에게 음주 30분 전 2정을 투여한 결과 52% 화이트와인 100g을 마신후에소 현기증을 느끼지 않았다. A 36-year-old male volunteer (surname "Zhang") who usually suffered from dizziness after drinking only a bottle of beer without drinking white wine was given two tablets 30 minutes before drinking. As a result, he did not feel dizzy after drinking 100g of 52% white wine. .

Claims (7)

주성분으로서 베조아 총 플라바논 추출물, 유사인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물로부터 선택된 1종 이상을 포함하는 것을 특징으로 하는,
항만취 및 숙취해소 조성물.
Characterized in that it contains at least one selected from bezoa total flavanone extract, pseudoginseng total flavanone extract and green tea total flavanone extract as a main component,
Anti-drinking and hangover-relieving composition.
제2항에 있어서,
상기 주성분은 중량부로서 베조아 총 플라바논 추출물 0-40, 유사 인삼 총 플라바논 추출물 0-40 및 녹차 총 플라바논 추출물 20-100을 포함하는,
조성물
According to claim 2,
The main component includes bezoa total flavanone extract 0-40, pseudo ginseng total flavanone extract 0-40 and green tea total flavanone extract 20-100 by weight,
composition
제1항 또는 제2항에 있어서,
상기 베조아 총 플라바논 추출물의 총 플라바논 함량은 >50%이고, 상기 유사 인삼 총 플라바논 추출물의 총 플라바논 함량은 >80%이고, 상기 녹차 총 플라바논 추출물의 총 플라바논 함량은 >80%인,
조성물.
According to claim 1 or 2,
The total flavanone content of the Bezoa total flavanone extract was >50%, the total flavanone content of the pseudoginseng total flavanone extract was >80%, and the total flavanone content of the green tea total flavanone extract was >80%. %person,
composition.
제3항에 있어서,
상기 베조아 총 플라바논 추출물, 상기 유사인삼 총 플라바논 추출물 및 상기 녹차 총 플라바논 추출물은:
베조아, 유사 인삼 및 녹차를 분쇄하는 단계;
상기 분쇄된 결과물을 각각 70% 미만 농도의 물 또는 에탄올로 추출하는 단계; 추출된 용액을 회수하는 단계;
원심분리 단계;
추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하는 단계;
40-50℃에서 진공 건조하는 단계; 및
각 추출물의 함량이 요구 사항을 충족하는지 확인하기 위해 검사하는 단계를 포함하는 방법에 의해 제조되는,
조성물.
According to claim 3,
The Bezoa total flavanone extract, the pseudoginseng total flavanone extract, and the green tea total flavanone extract are:
Grinding bezoa, pseudo ginseng and green tea;
Extracting the pulverized product with water or ethanol at a concentration of less than 70%, respectively; recovering the extracted solution;
centrifugation step;
performing extraction, macroporous resin column chromatography or recrystallization;
vacuum drying at 40-50°C; and
manufactured by a method comprising the step of inspecting the content of each extract to ensure that it meets the requirements;
composition.
제3항에 있어서,
β-시클로덱스트린, 말토덱스트린 및 스테비오사이드 중에서 선택된 1종 이상을 포함하는 보조성분을 더 포함하는,
조성물.
According to claim 3,
Further comprising an auxiliary component comprising at least one selected from β-cyclodextrin, maltodextrin and stevioside,
composition.
제5항에 있어서,
상기 주성분과 상기 보조성분의 중량비는 1:(0-3)인,
조성물.
According to claim 5,
The weight ratio of the main component and the auxiliary component is 1: (0-3),
composition.
항만취 및 숙취해소 조성물의 제조 방법으로서, 상기 방법은:
(1) 베조아, 유사 인삼 및 녹차를 분쇄하고; 상기 분쇄된 결과물을 각각 70% 미만 농도의 물 또는 에탄올로 추출하고; 추출된 용액을 회수하고; 원심분리하고; 추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조하고; 각 추출물의 함량이 요구 사항을 충족하는지 확인하여 베조아 총 플라바논 추출물, 유사 인삼 총 플라바논 추출물 및 녹차 총 플라바논 추출물을 얻고; 및 각각의 추출물을 분쇄하고 60메시체로 체과하는 단계;
(2) 베조아 총 플라바논 추출물 0-40, 녹차 총 플라바논 추출물 0-40 및 녹차 총 플라바논 추출물 20-100을 중량부로 칭량하고, 이들을 균일하게 혼합하여 주성분을 얻는 단계;
(3) β-시클로덱스트린 0-100 및 말토덱스트린 0-100을 중량부로 칭량하여 주성분과 균일하게 혼합하고, 전체 중량에 대하여 10-50%의 물을 첨가하고 갈기(grinding), 진공건조, 분쇄 및 60 메쉬 체로 체질을 단계; 그리고
(4) 스테비오사이드 0~20중량부를 첨가하여 균일하게 혼합, 멸균, 펠렛화하여 캡슐제, 정제 또는 연약제로 제조하는 단계;
를 포함하는,
방법.

A method for preparing an anti-drunk and hangover-relieving composition, the method comprising:
(1) crushing bezoa, ginseng pseudoginseng and green tea; Extracting the pulverized product with water or ethanol at a concentration of less than 70%, respectively; recovering the extracted solution; centrifuged; performing extraction, macroporous resin column chromatography or recrystallization; vacuum dried at 40-50°C; verifying whether the content of each extract meets the requirements to obtain bezoa total flavanone extract, pseudoginseng total flavanone extract and green tea total flavanone extract; And crushing each extract and sieving through a 60 mesh sieve;
(2) weighing 0-40 parts of bezoa total flavanone extract, 0-40 green tea total flavanone extract and 20-100 green tea total flavanone extract by weight, and mixing them uniformly to obtain a main component;
(3) Weigh 0-100 β-cyclodextrin and 0-100 maltodextrin by weight, mix them uniformly with the main component, add 10-50% of water based on the total weight, and grind, vacuum dry, and grind and sieving with a 60 mesh sieve; and
(4) adding 0 to 20 parts by weight of stevioside, mixing uniformly, sterilizing, and pelletizing to prepare capsules, tablets or soft medicines;
including,
method.

KR1020210142434A 2021-10-25 2021-10-25 An anti-drunkenness and hangover-alleviating composition and its preparation method KR20230058792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210142434A KR20230058792A (en) 2021-10-25 2021-10-25 An anti-drunkenness and hangover-alleviating composition and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210142434A KR20230058792A (en) 2021-10-25 2021-10-25 An anti-drunkenness and hangover-alleviating composition and its preparation method

Publications (1)

Publication Number Publication Date
KR20230058792A true KR20230058792A (en) 2023-05-03

Family

ID=86381032

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210142434A KR20230058792A (en) 2021-10-25 2021-10-25 An anti-drunkenness and hangover-alleviating composition and its preparation method

Country Status (1)

Country Link
KR (1) KR20230058792A (en)

Similar Documents

Publication Publication Date Title
Qi et al. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice
US20060233896A1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, Cistanche tubulosa (Schenk.) Wight, process of making the same, and uses of the same
CN107050148B (en) Traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver and preparation method thereof
Kumar et al. Effect of Helicteres isora bark extract on blood glucose and hepatic enzymes in experimental diabetes
WO2010037256A1 (en) Composition for reducing blood fat and blood glucose
WO2006063515A1 (en) Use of radix sanguisorbae and its extract for preparing medicament to increase rbc and hemoglobin
CN104997883A (en) Inonotus obliquus raspberry tree red raspberry composition, inonotus obliquus raspberry tree red raspberry composite oral solution and preparation method and application thereof
CN103053897B (en) A kind of ginseng polysaccharide chewable tablet and preparation method thereof
CN108210755B (en) Traditional Chinese medicine preparation for preventing and treating phlegm-dampness accumulation type hypertension and preparation method thereof
KR20200009824A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
CN108077727A (en) A kind of lotus leaf balsam pear plant amylum food of reducing blood lipid and preparation method thereof
KR20230058792A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
CN103211957A (en) Alcohol relieving and liver protecting composition and application thereof
CN106389483A (en) Medical fungi formula for preventing and treating diabetes and preparation method of medical fungi formula
CN101028437B (en) Chinese-medicinal effective part composition for preventing cardiovascular disease and its production
DE102018117603A1 (en) Anti-drunk and hangover relief composition and method of manufacture
DE102018115517A1 (en) Anti-intoxication and hangover mitigating composition and its preparation process
CA2667829A1 (en) Ingestibles containing beneficial diabetic ingredient
CN104940263A (en) Composition with functions of alleviating hangover and protecting liver and preparation method of composition
CN101732578A (en) Medicinal composition for treating essential hypertension, preparation method and use thereof
CN104622993B (en) Chewable tablet with protective effect on alcoholic liver injuries and preparation method of chewable tablet
EP1498131B1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa
KR20200020287A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
DE102019203483A1 (en) AN ANTI-DRUNK AND HANGOVER RELIEF COMPOSITION AND THEIR METHOD OF MANUFACTURING
KR20200004196A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method